Biomarker strategies to predict need for renal replacement therapy in acute kidney injury

Seminars in Dialysis

Volumn 24, Issue 2, 2011, Pages 124-131

  Cruz, Dinna N ^a,b   de Geus, Hilde R ^c   Bagshaw, Sean M ^d  

^a SAN BORTOLO HOSPITAL   (Italy)

^b International Renal Research Institute Vicenza (IRRIV)   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD; HUMAN; RENAL REPLACEMENT THERAPY;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; HUMANS; LIPOCALINS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RENAL REPLACEMENT THERAPY;

EID: 79955119486     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00830.x     Document Type: Article

References (41)

1. Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008-1016, 2008
2. Soni SS, Fahuan Y, Ronco C, Cruz DN: Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Biomark Med 3:549-560, 2009
3. Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl 241:89-94, 2008
4. Mishra J, Dent C, Tarabishi R, et al.: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231-1238, 2005
5. Hirsch R, Dent C, Pfriem H, Allen J, Beekman RH, 3rd, Ma Q, Dastrala S, Bennett M, Mitsnefes M, Devarajan P: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 22:2089-2095, 2007
6. Makris K, Markou N, Evodia E, et al.: Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med 47:79-82, 2009
7. Cruz DN, de Cal M, Garzotto F, et al.: Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med 36:444-451, 2010
8. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A: Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54:1012-1024, 2009
9. Wheeler DS, Devarajan P, Ma Q, et al.: Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36:1297-1303, 2008
10. Constantin JM, Futier E, Perbet S, et al.: Plasma neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in adult critically ill patients: a prospective study. J Crit Care 25:176e1-e6, 2010
11. Siew ED, Ware LB, Gebretsadik T, et al.: Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 20:1823-1832, 2009
12. Herget-Rosenthal S, van Wijk JA, Brocker-Preuss M, Bokenkamp A: Increased urinary cystatin C reflects structural and functional renal tubular impairment independent of glomerular filtration rate. Clin Biochem 40:946-951, 2007
13. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40:221-226, 2002
14. Fricker M, Wiesli P, Brandle M, Schwegler B, Schmid C: Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63:1944-1947, 2003
15. Manetti L, Pardini E, Genovesi M, et al.: Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 28:346-349, 2005
16. Manetti L, Genovesi M, Pardini E, et al.: Early effects of methylprednisolone infusion on serum cystatin C in patients with severe Graves' ophthalmopathy. Clin Chim Acta 356:227-228, 2005
17. Keller CR, Odden MC, Fried LF, et al.: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 71:239-244, 2007
18. Kos J, Stabuc B, Cimerman N, Brunner N: Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem 44:2556-2557, 1998
19. Herget-Rosenthal S, Marggraf G, Husing J, et al.: Early detection of acute renal failure by serum cystatin C. Kidney Int 66:1115-1122, 2004
20. Vaidya VS, Waikar SS, Ferguson MA, et al.: Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin Transl Sci 1:200-208, 2008
21. Ahlstrom A, Tallgren M, Peltonen S, Pettila V: Evolution and predictive power of serum cystatin C in acute renal failure. Clin Nephrol 62:344-350, 2004
22. Nejat M, Pickering JW, Walker RJ, Endre ZH: Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transplant 25:3283-3289, 2010
23. Perianayagam MC, Seabra VF, Tighiouart H, Liangos O, Jaber BL: Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 54:1025-1033, 2009
24. Koyner JL, Bennett MR, Worcester EM, et al.: Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 74:1059-1069, 2008
25. Haase-Fielitz A, Bellomo R, Devarajan P, et al.: Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 37:553-560, 2009
26. Herget-Rosenthal S, Poppen D, Husing J, et al.: Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 50:552-558, 2004
27. Price RG: The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 38(Suppl 1):S14-S19, 1992
28. Liangos O, Perianayagam MC, Vaidya VS, et al.: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18:904-912, 2007
29. Nickolas TL, O'Rourke MJ, Yang J, et al.: Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148:810-819, 2008
30. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 62:237-244, 2002
31. Han WK, Alinani A, Wu CL, et al.: Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 16:1126-1134, 2005
32. Bagshaw SM, Cruz DN, Gibney RN, Ronco C: A proposed algorithm for initiation of renal replacement therapy in adult critically ill patients. Crit Care 13:317, 2009
33. Gibney N, Hoste E, Burdmann EA, et al.: Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 3:876-880, 2008
34. Palevsky PM: Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 36:S224-S228, 2008
35. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL: Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 52:272-284, 2008
36. Bell M, Liljestam E, Granath F, Fryckstedt J, Ekbom A, Martling CR: Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria. Nephrol Dial Transplant 20:354-360, 2005
37. Shiao CC, Wu VC, Li WY, et al.: Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care 13:R171, 2009
38. Dickstein K, Cohen-Solal A, Filippatos G, et al.: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388-2442, 2008
39. Wagener G, Jan M, Kim M, et al.: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105:485-491, 2006
40. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT: Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 52:425-433, 2008
41. Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P: Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 3:665-673, 2008